Cargando…

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer

DNA abnormalities are used in inclusion criteria of clinical trials for treatments with specific targeted molecules. MYC is one of the most powerful oncogenes and is known to be associated with triple-negative breast cancer (TNBC). Its DNA amplification is often part of the targeted DNA-sequencing p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katsuta, Eriko, Yan, Li, Takeshita, Takashi, McDonald, Kerry-Ann, Dasgupta, Subhamoy, Opyrchal, Mateusz, Takabe, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981812/ https://www.ncbi.nlm.nih.gov/pubmed/31905596 http://dx.doi.org/10.3390/ijms21010217

Ejemplares similares

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2021)

Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2022)

Editorial: Novel signaling pathways and therapy in breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2023)

Dissecting transcriptional amplification by MYC
por: Nie, Zuqin, et al.
Publicado: (2020)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

MYC amplification in leukemia detected by cytogenetics
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2021)

Myc and mRNA capping()
por: Dunn, Sianadh, et al.
Publicado: (2015)

Elevated myc expression and c-myc amplification in spontaneously occurring B lymphoid cell lines
Publicado: (1987)

Detection of MYC gene amplification in malignant lymphomas.
por: Park, C. K., et al.
Publicado: (1998)

MYC amplifications are common events in childhood osteosarcoma
por: De Noon, Solange, et al.
Publicado: (2021)

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance
por: Deming, S L, et al.
Publicado: (2000)

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
por: Combaret, V., et al.
Publicado: (1997)

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
por: Abdou, Yara, et al.
Publicado: (2022)

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer
por: Schulze, Amy, et al.
Publicado: (2020)

Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
por: Ibrahim, Dina, et al.
Publicado: (2022)

Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma
por: Katsuta, Eriko, et al.
Publicado: (2020)

MYCL1 Amplification and Expression of L-Myc and c-Myc in Surgically Resected Small-Cell Lung Carcinoma
por: Qin, Jing, et al.
Publicado: (2021)

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?
por: Gupta, Ravi Kumar, et al.
Publicado: (2022)

Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone
por: Ueda, Takafumi, et al.
Publicado: (1997)

Loss of retinoblastoma gene and amplification of N-myc gene in retinoblastoma.
por: Choi, S. W., et al.
Publicado: (1993)

Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma
por: Kurisetty, Vittal, et al.
Publicado: (2013)

MYC Amplification in Angiosarcoma Arising from an Arteriovenous Graft Site
por: Paral, Kristen M., et al.
Publicado: (2015)

MYC amplification in subtypes of breast cancers in African American women
por: Naab, Tammey J., et al.
Publicado: (2018)

Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth
por: Vilborg, A, et al.
Publicado: (2012)

C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)

High expression of bone morphogenetic protein (BMP) 6 and BMP7 are associated with higher immune cell infiltration and better survival in estrogen receptor-positive breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy
por: Terakawa, Tomoaki, et al.
Publicado: (2018)

Registered report: Transcriptional amplification in tumor cells with elevated c-Myc
por: Blum, David, et al.
Publicado: (2015)

Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc
por: Lewis, L Michelle, et al.
Publicado: (2018)

The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer
por: Pan, Weiyu, et al.
Publicado: (2020)

MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975
por: Tang, Minhong, et al.
Publicado: (2022)

Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors
por: Katsuta, Eriko, et al.
Publicado: (2022)

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides
por: Gill, Taylor, et al.
Publicado: (2021)

Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis
por: Moumen, Mejdi, et al.
Publicado: (2013)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j5m9sgt4cb00274vdc3kt0e669